Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, SALINE clinical trials

Does the Glucagon-like Peptide 1 (GLP-1) receptor agonist semaglutide reduce alcohol intake in patients with Alcohol Use Disorder and comorbid obesity?

This study is looking into whether a medicine called semaglutide, which is usually for diabetes and weight loss, can help people with alcohol use disorder who also have obesity to drink less alcohol. It's an early-stage study to see if it works.